Titre:
  • BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy.
Auteur:Héritier, Sébastien; Emile, Jean-François; Barkaoui, Mohamed-Aziz; Thomas, Caroline; Fraitag, Sylvie; Boudjemaa, Sabah; Renaud, Florence; Moreau, Anne; Peuchmaur, Michel; Chassagne-Clement, Catherine; Dijoud, Frédérique; Rigau, Valérie; Moshous, Despina; Lambilliotte, Anne; Mazingue, Françoise; Kebaili, Kamila; Miron, Jean; Jeziorski, Eric; Plat, Geneviève; Aladjidi, Nathalie; Ferster, Alina; Pacquement, Hélène; Galambrun, Claire; Brugières, Laurence; Leverger, Guy; Mansuy, Ludovic; Paillard, Catherine; Deville, Anne; Armari-Alla, Corinne; Lutun, Anne; Gillibert-Yvert, Marion; Stephan, Jean Louis; Cohen-Aubart, Fleur; Haroche, Julien; Pellier, Isabelle; Millot, Frédéric; Lescoeur, Brigitte; Gandemer, Virginie; Bodemer, Christine; Lacave, Roger; Hélias-Rodzewicz, Zofia; Taly, Valérie; Geissmann, Frédéric; Donadieu, Jean
Informations sur la publication:Journal of clinical oncology, 34, 25, page (3023-3030)
Statut de publication:Publié, 2016-09
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adolescent
Adrenal Cortex Hormones -- administration & dosage
Antineoplastic Combined Chemotherapy Protocols -- pharmacology -- therapeutic use
Child
Child, Preschool
Cohort Studies
Drug Resistance, Neoplasm
Female
France -- epidemiology
Histiocytosis, Langerhans-Cell -- drug therapy -- enzymology -- epidemiology -- genetics
Humans
Infant
Infant, Newborn
Male
Molecular Targeted Therapy
Mutation
Proto-Oncogene Proteins B-raf -- antagonists & inhibitors -- genetics
Registries
Vinblastine -- administration & dosage
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2015.65.9508
info:pii/JCO.2015.65.9508
info:pmid/27382093
PMC5321082